Matches in Nanopublications for { ?s ?p "[These data suggest that Wnt/?-catenin signaling is a key downstream effector of MET signaling and contributes to the maintenance of GSC and GBM malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[These data suggest that Wnt/?-catenin signaling is a key downstream effector of MET signaling and contributes to the maintenance of GSC and GBM malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These data suggest that Wnt/?-catenin signaling is a key downstream effector of MET signaling and contributes to the maintenance of GSC and GBM malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP736811.RAPlVhR68PYiDU_uLjS5ptzG92JyzInM6en_X3xApkphw130_assertion description "[These data suggest that Wnt/?-catenin signaling is a key downstream effector of MET signaling and contributes to the maintenance of GSC and GBM malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP736811.RAPlVhR68PYiDU_uLjS5ptzG92JyzInM6en_X3xApkphw130_provenance.
- NP974192.RAnCtIHp1oSiMq_3lv5_WCDiQE_wnyDSW-to8QHvMkRD8130_assertion description "[These data suggest that Wnt/?-catenin signaling is a key downstream effector of MET signaling and contributes to the maintenance of GSC and GBM malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP974192.RAnCtIHp1oSiMq_3lv5_WCDiQE_wnyDSW-to8QHvMkRD8130_provenance.
- NP974200.RApJ5NlIVdIO2yOdaOmvbfws6az7qhcwLNBPu7_TfalvI130_assertion description "[These data suggest that Wnt/?-catenin signaling is a key downstream effector of MET signaling and contributes to the maintenance of GSC and GBM malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP974200.RApJ5NlIVdIO2yOdaOmvbfws6az7qhcwLNBPu7_TfalvI130_provenance.
- NP913907.RAH4JI1kFl2VHGjUN-3BaPR8MQN4GSz8Lb5KM7ww9hGqY130_assertion description "[These data suggest that Wnt/?-catenin signaling is a key downstream effector of MET signaling and contributes to the maintenance of GSC and GBM malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913907.RAH4JI1kFl2VHGjUN-3BaPR8MQN4GSz8Lb5KM7ww9hGqY130_provenance.
- NP1037871.RAH8FxrKs7E6Wb1YU_RtxmEjB07aA0EL4b-glcHzoWm3Y130_assertion description "[These data suggest that Wnt/?-catenin signaling is a key downstream effector of MET signaling and contributes to the maintenance of GSC and GBM malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1037871.RAH8FxrKs7E6Wb1YU_RtxmEjB07aA0EL4b-glcHzoWm3Y130_provenance.
- NP974223.RA85Q_blESM4TrxLrSNuQFCgKbVhwIghrshTkcjyJyPLw130_assertion description "[These data suggest that Wnt/?-catenin signaling is a key downstream effector of MET signaling and contributes to the maintenance of GSC and GBM malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP974223.RA85Q_blESM4TrxLrSNuQFCgKbVhwIghrshTkcjyJyPLw130_provenance.